近年来,关于降压药与糖尿病风险的话题一直不绝于耳。最近,他汀治疗相关性高血糖又成为热议的话题。的确,一些降压药物与多数他汀在发挥治疗作用的同时,可能会轻度增加新发糖尿病风险,但这一不利影响并不值得过分关注,更不应大肆渲染,以免影响这些药物的合理应用。首先,无论降压药物还是他汀,只要按照现行指南原则合理应用,均可以显著改善患者预后。迄今并无证据表明药物对糖代谢的作用会对临床预后产生有意义的影响。例如,虽然长期大 In recent years, the topic of antihypertensive drugs and diabetes risk has been endless. Recently, statin-related hyperglycemia has become a hot topic. Indeed, some antihypertensive drugs and most statins may play a therapeutic role at the same time, may slightly increase the risk of new onset diabetes, but this adverse effect is not worth the excessive attention, but should not be hyped, so as not to affect the rational use of these drugs . First of all, regardless of antihypertensive drugs or statins, as long as the use of the principle of the current guidelines reasonable application, can significantly improve patient outcomes. So far there is no evidence that the effect of drugs on glucose metabolism will have a meaningful impact on clinical outcomes. For example, although long-term big